 | • レポートコード：20QY06-06493 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、住血吸虫症薬のグローバル市場について種類別（プラジカンテル、オキサムニキン、その他）、用途別（S.ヘマトビウム、S.マンソニ、S.ジャポニカム、S.メコン住血吸虫、S.インターカラタム住血吸虫）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・住血吸虫症薬市場の概要 ・世界の主要地域別住血吸虫症薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の住血吸虫症薬市場規模2015-2026：種類別（プラジカンテル、オキサムニキン、その他） ・世界の住血吸虫症薬市場規模2015-2026：用途別（S.ヘマトビウム、S.マンソニ、S.ジャポニカム、S.メコン住血吸虫、S.インターカラタム住血吸虫） ・住血吸虫症薬の北米市場規模2015-2020 ・住血吸虫症薬のヨーロッパ市場規模2015-2020 ・住血吸虫症薬の中国市場規模2015-2020 ・住血吸虫症薬の日本市場規模2015-2020 ・住血吸虫症薬の東南アジア市場規模2015-2020 ・住血吸虫症薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Shin Poong、Merck、Bayer、EIPICO、Chandra Bhagat Pharma、Taj Pharmaceuticals） ・住血吸虫症薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・住血吸虫症薬の市場動向・機会・課題 ・調査の結論 |
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
The global average price of Drugs for Schistosomiasis is in the decreasing trend, from 62 USD/K Units in 2011 to 57 USD/K Units in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
Market Analysis and Insights: Global Drugs for Schistosomiasis Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Drugs for Schistosomiasis market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Drugs for Schistosomiasis industry.
Based on our recent survey, we have several different scenarios about the Drugs for Schistosomiasis YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 76 million in 2019. The market size of Drugs for Schistosomiasis will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Drugs for Schistosomiasis Scope and Market Size
The global Drugs for Schistosomiasis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Schistosomiasis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Drugs for Schistosomiasis market is segmented into
Praziquantel
Oxamniquine
Other
Segment by Application, the Drugs for Schistosomiasis market is segmented into
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
The Drugs for Schistosomiasis market is analysed and market size information is provided by regions (countries). Segment by Application, the Drugs for Schistosomiasis market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Drugs for Schistosomiasis Market Share Analysis
Drugs for Schistosomiasis market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Drugs for Schistosomiasis business, the date to enter into the Drugs for Schistosomiasis market, Drugs for Schistosomiasis product introduction, recent developments, etc.
The major vendors covered:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
…
1 Drugs for Schistosomiasis Market Overview
1.1 Drugs for Schistosomiasis Product Scope
1.2 Drugs for Schistosomiasis Segment by Type
1.2.1 Global Drugs for Schistosomiasis Sales by Type (2020-2026)
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Drugs for Schistosomiasis Segment by Application
1.3.1 Global Drugs for Schistosomiasis Sales Comparison by Application (2020-2026)
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Drugs for Schistosomiasis Market Estimates and Forecasts (2015-2026)
1.4.1 Global Drugs for Schistosomiasis Sales Growth Rate (2015-2026)
1.4.2 Global Drugs for Schistosomiasis Revenue and Growth Rate (2015-2026)
1.4.3 Global Drugs for Schistosomiasis Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Drugs for Schistosomiasis Industry Impact
1.5.1 How the Covid-19 is Affecting the Drugs for Schistosomiasis Industry
1.5.1.1 Drugs for Schistosomiasis Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Drugs for Schistosomiasis Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Drugs for Schistosomiasis Players to Combat Covid-19 Impact
2 Drugs for Schistosomiasis Estimate and Forecast by Region
2.1 Global Drugs for Schistosomiasis Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Drugs for Schistosomiasis Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Drugs for Schistosomiasis Sales Market Share by Region (2015-2020)
2.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Region (2015-2020)
2.3 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Drugs for Schistosomiasis Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Drugs for Schistosomiasis Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Drugs for Schistosomiasis Estimates and Projections (2015-2026)
2.4.2 Europe Drugs for Schistosomiasis Estimates and Projections (2015-2026)
2.4.3 China Drugs for Schistosomiasis Estimates and Projections (2015-2026)
2.4.4 Japan Drugs for Schistosomiasis Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Drugs for Schistosomiasis Estimates and Projections (2015-2026)
2.4.6 India Drugs for Schistosomiasis Estimates and Projections (2015-2026)
3 Global Drugs for Schistosomiasis Competition Landscape by Players
3.1 Global Top Drugs for Schistosomiasis Players by Sales (2015-2020)
3.2 Global Top Drugs for Schistosomiasis Players by Revenue (2015-2020)
3.3 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Schistosomiasis as of 2019)
3.4 Global Drugs for Schistosomiasis Average Price by Company (2015-2020)
3.5 Manufacturers Drugs for Schistosomiasis Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Drugs for Schistosomiasis Players (Opinion Leaders)
4 Global Drugs for Schistosomiasis Market Size by Type
4.1 Global Drugs for Schistosomiasis Historic Market Review by Type (2015-2020)
4.1.1 Global Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
4.1.2 Global Drugs for Schistosomiasis Revenue Market Share by Type (2015-2020)
4.1.3 Global Drugs for Schistosomiasis Price by Type (2014-2020)
4.2 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Drugs for Schistosomiasis Sales Forecast by Type (2021-2026)
4.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Type (2021-2026)
4.2.3 Global Drugs for Schistosomiasis Price Forecast by Type (2021-2026)
5 Global Drugs for Schistosomiasis Market Size by Application
5.1 Global Drugs for Schistosomiasis Historic Market Review by Application (2015-2020)
5.1.1 Global Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
5.1.2 Global Drugs for Schistosomiasis Revenue Market Share by Application (2015-2020)
5.1.3 Global Drugs for Schistosomiasis Price by Application (2015-2020)
5.2 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Drugs for Schistosomiasis Sales Forecast by Application (2021-2026)
5.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Application (2021-2026)
5.2.3 Global Drugs for Schistosomiasis Price Forecast by Application (2021-2026)
3 North America Drugs for Schistosomiasis Market Facts & Figures
3.2 North America Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
3.3 North America Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
3.4 North America Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
4 Europe Drugs for Schistosomiasis Market Facts & Figures
4.2 Europe Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
4.3 Europe Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
4.4 Europe Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
5 China Drugs for Schistosomiasis Market Facts & Figures
5.2 China Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
5.3 China Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
5.4 China Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
6 Japan Drugs for Schistosomiasis Market Facts & Figures
6.2 Japan Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
6.3 Japan Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
6.4 Japan Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
7 Southeast Asia Drugs for Schistosomiasis Market Facts & Figures
7.2 Southeast Asia Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
8 India Drugs for Schistosomiasis Market Facts & Figures
8.2 India Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
8.3 India Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
8.4 India Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Drugs for Schistosomiasis Business
12.1 Shin Poong
12.1.1 Shin Poong Drugs for Schistosomiasis Corporation Information
12.1.2 Shin Poong Drugs for Schistosomiasis Business Overview and Total Revenue
12.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Shin Poong Drugs for Schistosomiasis Products Offered
12.1.5 Shin Poong Recent Development
12.2 Merck
12.2.1 Merck Drugs for Schistosomiasis Corporation Information
12.2.2 Merck Drugs for Schistosomiasis Business Overview and Total Revenue
12.2.3 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Drugs for Schistosomiasis Products Offered
12.2.5 Merck Recent Development
12.3 Bayer
12.3.1 Bayer Drugs for Schistosomiasis Corporation Information
12.3.2 Bayer Drugs for Schistosomiasis Business Overview and Total Revenue
12.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer Drugs for Schistosomiasis Products Offered
12.3.5 Bayer Recent Development
12.4 EIPICO
12.4.1 EIPICO Drugs for Schistosomiasis Corporation Information
12.4.2 EIPICO Drugs for Schistosomiasis Business Overview and Total Revenue
12.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2015-2020)
12.4.4 EIPICO Drugs for Schistosomiasis Products Offered
12.4.5 EIPICO Recent Development
12.5 Chandra Bhagat Pharma
12.5.1 Chandra Bhagat Pharma Drugs for Schistosomiasis Corporation Information
12.5.2 Chandra Bhagat Pharma Drugs for Schistosomiasis Business Overview and Total Revenue
12.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Products Offered
12.5.5 Chandra Bhagat Pharma Recent Development
12.6 Taj Pharmaceuticals
12.6.1 Taj Pharmaceuticals Drugs for Schistosomiasis Corporation Information
12.6.2 Taj Pharmaceuticals Drugs for Schistosomiasis Business Overview and Total Revenue
12.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Products Offered
12.6.5 Taj Pharmaceuticals Recent Development
…
13 Drugs for Schistosomiasis Manufacturing Cost Analysis
13.1 Drugs for Schistosomiasis Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Drugs for Schistosomiasis
13.4 Drugs for Schistosomiasis Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Drugs for Schistosomiasis Distributors List
14.3 Drugs for Schistosomiasis Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Drugs for Schistosomiasis Sales (M Units) Growth Rate by Type (2020-2026)
Table 2. Global Drugs for Schistosomiasis Sales (M Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Drugs for Schistosomiasis Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Drugs for Schistosomiasis Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Drugs for Schistosomiasis Players to Combat Covid-19 Impact
Table 8. Global Market Drugs for Schistosomiasis Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Drugs for Schistosomiasis Sales (M Units) by Region (2015-2020)
Table 10. Global Drugs for Schistosomiasis Sales Market Share by Region (2015-2020)
Table 11. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Drugs for Schistosomiasis Revenue Share by Region (2015-2020)
Table 13. Global Drugs for Schistosomiasis Sales (M Units) Forecast by Region (2021-2026)
Table 14. Global Drugs for Schistosomiasis Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Drugs for Schistosomiasis Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Drugs for Schistosomiasis Revenue Share Forecast by Region (2021-2026)
Table 17. Global Drugs for Schistosomiasis (M Units) of Key Companies (2015-2020)
Table 18. Global Drugs for Schistosomiasis Sales Share by Company (2015-2020)
Table 19. Global Drugs for Schistosomiasis Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Drugs for Schistosomiasis Revenue Share by Company (2015-2020)
Table 21. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Schistosomiasis as of 2019)
Table 22. Global Drugs for Schistosomiasis Average Price (USD/K Units) of Key Company (2015-2020)
Table 23. Manufacturers Drugs for Schistosomiasis Manufacturing Sites and Area Served
Table 24. Manufacturers Drugs for Schistosomiasis Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Drugs for Schistosomiasis Players
Table 27. Global Drugs for Schistosomiasis Sales (M Units) by Type (2015-2020)
Table 28. Global Drugs for Schistosomiasis Sales Share by Type (2015-2020)
Table 29. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Drugs for Schistosomiasis Price (M Units) by Type (2015-2020)
Table 31. Global Drugs for Schistosomiasis Sales Share by Type (2021-2026)
Table 32. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Drugs for Schistosomiasis Revenue Share by Type (2021-2026)
Table 34. Global Drugs for Schistosomiasis Price (M Units) by Type (2021-2026)
Table 35. Global Drugs for Schistosomiasis Sales (M Units) by Application (2015-2020)
Table 36. Global Drugs for Schistosomiasis Sales Share by Application (2015-2020)
Table 37. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Drugs for Schistosomiasis Price (M Units) by Application (2015-2020)
Table 39. Global Drugs for Schistosomiasis Sales (M Units) by Application (2021-2026)
Table 40. Global Drugs for Schistosomiasis Sales Share by Application (2021-2026)
Table 41. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Drugs for Schistosomiasis Revenue Share by Application (2021-2026)
Table 43. Global Drugs for Schistosomiasis Price (M Units) by Application (2021-2026)
Table 44. United States Drugs for Schistosomiasis Sales (M Units) by Company (2015-2020)
Table 45. United States Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
Table 46. United States Drugs for Schistosomiasis Sales (M Units) by Type (2015-2020)
Table 47. United States Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
Table 48. United States Drugs for Schistosomiasis Sales (M Units) by Application (2015-2020)
Table 49. United States Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
Table 50. Europe Drugs for Schistosomiasis Sales (M Units) by Company (2015-2020)
Table 51. Europe Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
Table 52. Europe Drugs for Schistosomiasis Sales (M Units) by Type (2015-2020)
Table 53. Europe Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
Table 54. Europe Drugs for Schistosomiasis Sales (M Units) by Application (2015-2020)
Table 55. Europe Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
Table 56. China Drugs for Schistosomiasis Sales (M Units) by Company (2015-2020)
Table 57. China Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
Table 58. China Drugs for Schistosomiasis Sales (M Units) by Type (2015-2020)
Table 59. China Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
Table 60. China Drugs for Schistosomiasis Sales (M Units) by Application (2015-2020)
Table 61. China Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
Table 62. Japan Drugs for Schistosomiasis Sales (M Units) by Company (2015-2020)
Table 63. Japan Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
Table 64. Japan Drugs for Schistosomiasis Sales (M Units) by Type (2015-2020)
Table 65. Japan Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
Table 66. Japan Drugs for Schistosomiasis Sales (M Units) by Application (2015-2020)
Table 67. Japan Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Drugs for Schistosomiasis Sales (M Units) by Company (2015-2020)
Table 69. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Drugs for Schistosomiasis Sales (M Units) by Type (2015-2020)
Table 71. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Drugs for Schistosomiasis Sales (M Units) by Type (2015-2020)
Table 73. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
Table 74. India Drugs for Schistosomiasis Sales (M Units) by Company (2015-2020)
Table 75. India Drugs for Schistosomiasis Sales Market Share by Company (2015-2020)
Table 76. India Drugs for Schistosomiasis Sales (M Units) by Type (2015-2020)
Table 77. India Drugs for Schistosomiasis Sales Market Share by Type (2015-2020)
Table 78. India Drugs for Schistosomiasis Sales (M Units) by Application (2015-2020)
Table 79. India Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
Table 80. Shin Poong Corporation Information
Table 81. Shin Poong Description and Business Overview
Table 82. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 83. Shin Poong Drugs for Schistosomiasis Product
Table 84. Shin Poong Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 88. Merck Drugs for Schistosomiasis Product
Table 89. Merck Recent Development
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 93. Bayer Drugs for Schistosomiasis Product
Table 94. Bayer Recent Development
Table 95. EIPICO Corporation Information
Table 96. EIPICO Description and Business Overview
Table 97. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 98. EIPICO Drugs for Schistosomiasis Product
Table 99. EIPICO Recent Development
Table 100. Chandra Bhagat Pharma Corporation Information
Table 101. Chandra Bhagat Pharma Description and Business Overview
Table 102. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 103. Chandra Bhagat Pharma Drugs for Schistosomiasis Product
Table 104. Chandra Bhagat Pharma Recent Development
Table . Taj Pharmaceuticals Corporation Information
Table . Taj Pharmaceuticals Description and Business Overview
Table . Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table . Taj Pharmaceuticals Drugs for Schistosomiasis Product
Table . Taj Pharmaceuticals Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Drugs for Schistosomiasis Distributors List
Table 113. Drugs for Schistosomiasis Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Schistosomiasis Product Picture
Figure 2. Global Drugs for Schistosomiasis Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Drugs for Schistosomiasis Market Share by Application in 2020 & 2026
Figure 6. S. haematobium Examples
Figure 7. S. mansoni Examples
Figure 8. S. japonicum Examples
Figure 9. S. mekongi Examples
Figure 10. S. intercalatum Examples
Figure 11. Global Drugs for Schistosomiasis Sales (M Units) Growth Rate (2015-2026)
Figure 12. Global Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Drugs for Schistosomiasis Price Trends Growth Rate (2015-2026) (USD/K Units)
Figure 14. Global Drugs for Schistosomiasis Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Drugs for Schistosomiasis Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Drugs for Schistosomiasis Sales (M Units) Growth Rate (2015-2026)
Figure 18. Europe Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Drugs for Schistosomiasis Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Drugs for Schistosomiasis Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Drugs for Schistosomiasis Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Drugs for Schistosomiasis Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Drugs for Schistosomiasis Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Drugs for Schistosomiasis Players Market Share by Revenue in Drugs for Schistosomiasis 2015 & 2019
Figure 29. Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Drugs for Schistosomiasis Revenue Share by Type (2015-2020)
Figure 31. Global Drugs for Schistosomiasis Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Drugs for Schistosomiasis Revenue Share by Application (2015-2020)
Figure 33. Global Drugs for Schistosomiasis Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Drugs for Schistosomiasis Sales Market Share by Type in 2019
Figure 35. United States Drugs for Schistosomiasis Sales Market Share by Type in 2019
Figure 36. Europe Drugs for Schistosomiasis Sales Market Share by Company in 2019
Figure 37. Europe Drugs for Schistosomiasis Sales Market Share by Type in 2019
Figure 38. Europe Drugs for Schistosomiasis Sales Market Share by Application in 2019
Figure 39. China Drugs for Schistosomiasis Sales Market Share by Company in 2019
Figure 40. China Drugs for Schistosomiasis Sales Market Share by Type in 2019
Figure 41. China Drugs for Schistosomiasis Sales Market Share by Application in 2019
Figure 42. Japan Drugs for Schistosomiasis Sales Market Share by Company in 2019
Figure 43. Japan Drugs for Schistosomiasis Sales Market Share by Type in 2019
Figure 44. Japan Drugs for Schistosomiasis Sales Market Share by Application in 2019
Figure 45. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Company in 2019
Figure 46. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Type in 2019
Figure 47. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Application in 2019
Figure 48. India Drugs for Schistosomiasis Sales Market Share by Company in 2019
Figure 49. India Drugs for Schistosomiasis Sales Market Share by Type in 2019
Figure 50. India Drugs for Schistosomiasis Sales Market Share by Application in 2019
Figure 51. Shin Poong Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. EIPICO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Chandra Bhagat Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Drugs for Schistosomiasis
Figure 59. Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure 60. Drugs for Schistosomiasis Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
エクセナチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Exenatide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…- リラグルチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Liraglutide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drugs Market The global Endocrine System Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Endocrine System Drugs Scope and Market Size The global…
- コリン作動薬の世界市場レポート2020 Market Analysis and Insights: Global Cholinergic Drugs Market The global Cholinergic Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cholinergic Drugs Scope and Market Size The global Cholinergic Dr…
- リンパ腫薬の世界市場レポート2020 Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control. The China average price of Lymphoma D…